Annual CFI
-$14.00 K
+$4.71 M+99.70%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual cash flow from investing activities is -$14.00 thousand, with the most recent change of +$4.71 million (+99.70%) on December 31, 2023.
- During the last 3 years, ATOS annual CFI has fallen by -$5000.00 (-55.56%).
Performance
ATOS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$10.00 K
-$7000.00-233.33%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly cash flow from investing activities is -$10.00 thousand, with the most recent change of -$7000.00 (-233.33%) on September 30, 2024.
- Over the past year, ATOS quarterly CFI has dropped by -$9000.00 (-900.00%).
- ATOS quarterly CFI is now -2600.00% below its all-time high of $400.00, reached on December 31, 2020.
Performance
ATOS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$19.00 K
-$9000.00-90.00%
September 30, 2024
Summary
- As of February 7, 2025, ATOS TTM cash flow from investing activities is -$19.00 thousand, with the most recent change of -$9000.00 (-90.00%) on September 30, 2024.
- Over the past year, ATOS TTM CFI has increased by +$2.00 million (+99.06%).
Performance
ATOS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ATOS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.7% | -900.0% | +99.1% |
| 3 y3 years | -55.6% | -11.1% | -120.9% |
| 5 y5 years | +87.4% | -11.1% | -120.9% |
ATOS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | +99.7% | <-9999.0% | +99.6% | -111.1% | +99.6% |
| 5 y | 5-year | -84.2% | +99.7% | -2600.0% | +99.6% | -691.7% | +99.6% |
| alltime | all time | <-9999.0% | +99.7% | -2600.0% | +99.6% | <-9999.0% | +99.6% |
Atossa Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.00 K(+233.3%) | -$19.00 K(+90.0%) |
| Jun 2024 | - | -$3000.00(-50.0%) | -$10.00 K(-50.0%) |
| Mar 2024 | - | -$6000.00(<-9900.0%) | -$20.00 K(+42.9%) |
| Dec 2023 | -$14.00 K(-99.7%) | $0.00(-100.0%) | -$14.00 K(-99.3%) |
| Sep 2023 | - | -$1000.00(-92.3%) | -$2.02 M(-57.2%) |
| Jun 2023 | - | -$13.00 K(<-9900.0%) | -$4.73 M(+0.3%) |
| Mar 2023 | - | $0.00(-100.0%) | -$4.71 M(-0.3%) |
| Dec 2022 | -$4.73 M(>+9900.0%) | -$2.01 M(-25.8%) | -$4.73 M(+73.9%) |
| Sep 2022 | - | -$2.71 M(<-9900.0%) | -$2.72 M(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$22.00 K(0.0%) |
| Mar 2022 | - | -$13.00 K(<-9900.0%) | -$22.00 K(+144.4%) |
| Dec 2021 | -$9000.00(0.0%) | $0.00(-100.0%) | -$9000.00(+4.7%) |
| Sep 2021 | - | -$9000.00(<-9900.0%) | -$8600.00(+258.3%) |
| Jun 2021 | - | $0.00(0.0%) | -$2400.00(-73.3%) |
| Mar 2021 | - | $0.00(-100.0%) | -$9000.00(0.0%) |
| Dec 2020 | -$9000.00(+18.4%) | $400.00(-114.3%) | -$9000.00(-4.3%) |
| Sep 2020 | - | -$2800.00(-57.6%) | -$9400.00(+42.4%) |
| Jun 2020 | - | -$6600.00(<-9900.0%) | -$6600.00(-13.2%) |
| Mar 2020 | - | $0.00(0.0%) | -$7600.00(0.0%) |
| Dec 2019 | -$7600.00(-93.1%) | $0.00(0.0%) | -$7600.00(-88.1%) |
| Sep 2019 | - | $0.00(-100.0%) | -$64.10 K(-4.5%) |
| Jun 2019 | - | -$7600.00(<-9900.0%) | -$67.10 K(+12.0%) |
| Mar 2019 | - | $0.00(-100.0%) | -$59.90 K(-46.0%) |
| Dec 2018 | -$110.90 K | -$56.50 K(+1783.3%) | -$111.00 K(+103.7%) |
| Sep 2018 | - | -$3000.00(+650.0%) | -$54.50 K(+5.8%) |
| Jun 2018 | - | -$400.00(-99.2%) | -$51.50 K(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$51.10 K(+1116.7%) | -$51.10 K(+455.4%) |
| Dec 2016 | -$9200.00(-96.8%) | -$4200.00(+4100.0%) | -$9200.00(-95.0%) |
| Sep 2016 | - | -$100.00(-200.0%) | -$182.70 K(-13.7%) |
| Jun 2016 | - | $100.00(-102.0%) | -$211.70 K(-6.9%) |
| Mar 2016 | - | -$5000.00(-97.2%) | -$227.40 K(-21.2%) |
| Dec 2015 | -$288.40 K(-16.0%) | -$177.70 K(+510.7%) | -$288.40 K(+73.3%) |
| Sep 2015 | - | -$29.10 K(+86.5%) | -$166.40 K(-28.8%) |
| Jun 2015 | - | -$15.60 K(-76.4%) | -$233.70 K(-23.7%) |
| Mar 2015 | - | -$66.00 K(+18.5%) | -$306.20 K(-10.8%) |
| Dec 2014 | -$343.30 K(-29.9%) | -$55.70 K(-42.2%) | -$343.20 K(-8.9%) |
| Sep 2014 | - | -$96.40 K(+9.4%) | -$376.60 K(-36.3%) |
| Jun 2014 | - | -$88.10 K(-14.5%) | -$591.00 K(+1.1%) |
| Mar 2014 | - | -$103.00 K(+15.6%) | -$584.30 K(+19.3%) |
| Dec 2013 | -$489.80 K(+263.9%) | -$89.10 K(-71.3%) | -$489.80 K(-8.5%) |
| Sep 2013 | - | -$310.80 K(+281.8%) | -$535.30 K(+138.4%) |
| Jun 2013 | - | -$81.40 K(+857.6%) | -$224.50 K(+56.9%) |
| Mar 2013 | - | -$8500.00(-93.7%) | -$143.10 K(+6.3%) |
| Dec 2012 | -$134.60 K(-1.7%) | -$134.60 K(<-9900.0%) | -$134.60 K(+160.3%) |
| Sep 2012 | - | $0.00(0.0%) | -$51.70 K(-23.2%) |
| Jun 2012 | - | $0.00(0.0%) | -$67.30 K(-50.9%) |
| Mar 2012 | - | $0.00(-100.0%) | -$137.00 K(0.0%) |
| Dec 2011 | -$136.90 K(<-9900.0%) | -$51.70 K(+231.4%) | -$137.00 K(+60.6%) |
| Sep 2011 | - | -$15.60 K(-77.6%) | -$85.30 K(+22.4%) |
| Jun 2011 | - | -$69.70 K(<-9900.0%) | -$69.70 K(<-9900.0%) |
| Mar 2011 | - | $0.00 | $0.00 |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is Atossa Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Atossa Therapeutics?
- What is Atossa Therapeutics annual CFI year-on-year change?
- What is Atossa Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly CFI year-on-year change?
- What is Atossa Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Atossa Therapeutics?
- What is Atossa Therapeutics TTM CFI year-on-year change?
What is Atossa Therapeutics annual cash flow from investing activities?
The current annual CFI of ATOS is -$14.00 K
What is the all time high annual CFI for Atossa Therapeutics?
Atossa Therapeutics all-time high annual cash flow from investing activities is $0.00
What is Atossa Therapeutics annual CFI year-on-year change?
Over the past year, ATOS annual cash flow from investing activities has changed by +$4.71 M (+99.70%)
What is Atossa Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ATOS is -$10.00 K
What is the all time high quarterly CFI for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly cash flow from investing activities is $400.00
What is Atossa Therapeutics quarterly CFI year-on-year change?
Over the past year, ATOS quarterly cash flow from investing activities has changed by -$9000.00 (-900.00%)
What is Atossa Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ATOS is -$19.00 K
What is the all time high TTM CFI for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is Atossa Therapeutics TTM CFI year-on-year change?
Over the past year, ATOS TTM cash flow from investing activities has changed by +$2.00 M (+99.06%)